Please login to the form below

Not currently logged in
Email:
Password:

Rexulti

This page shows the latest Rexulti news and features for those working in and with pharma, biotech and healthcare.

Lundbeck and Otsuka start phase III for Rexulti in bipolar

Lundbeck and Otsuka start phase III for Rexulti in bipolar

Lundbeck and Otsuka start phase III for Rexulti in bipolar. Drug is also in phase II trial to treat PTSD patients. ... To date Rexulti has only been launched in the US, Canada and Australia, although it was filed for approval in Europe in schizophrenia

Latest news

More from news
Approximately 3 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics